Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating promising results in the management of type 2 diabetes. This synthetic peptide mimics the actions of naturally present GLP-1, a hormone https://socialmphl.com/story23032492/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes